Inhibitors of lipoxygenase: A new class of cancer chemopreventive agents

Carcinogenesis

Volumn 19, Issue 8, 1998, Pages 1393-1400

  Rioux, Nathalie ^a   Castonguay, Andre ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 [5 (4 FLUOROPHENOXY) 2 FURYL] 1 METHYL 2 PROPYNYL] 1 HYDROXYUREA; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ACETYLSALICYLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG HYDROXYLATION; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATION; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; ANTICARCINOGENIC AGENTS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; ASPIRIN; BODY WEIGHT; CARCINOGENS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HYDROXYUREA; INDOLES; LIPOXYGENASE INHIBITORS; LUNG NEOPLASMS; MICE; MICE, INBRED A; NEOPLASMS, EXPERIMENTAL; NITROSAMINES;

EID: 0031705797     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.8.1393     Document Type: Article

References (49)

1. Heath,C.W., Thun,M.J., Greenberg,E.R., Levin,B. and Marnett,L.J. (1994) Nonsteroidal antiinflammatory drugs and human cancer. Report of an interdiciplinary research workshop. Cancer, 74, 2885-2888.
2. Marnett,L.J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575-5589.
3. Pepin,P., Bouchard,L., Nicole,P. and Castonguay,A. (1992) Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice. Carcinogenesis, 13, 341-348.
4. Jalbert,G and Castonguay,A. (1992) Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett., 66, 21-28.
5. Duperron,C and Castonguay,A. (1997) Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis, 18, 1001-1006.
6. Shimizu,T, Izumi,T., Seyama,Y., Tadokor, K., Radmark,O. and Samuelsson. (1986) Characterization of leukotriene A4 synthase from murine mast cells: evidence for its identity to arachidonate. Proc. Natl Acad. Sci. USA, 83, 4175-4179.
7. Dixon,R.A.F., Diehl,R.E., Opas,E., Rands,E., Vickers,P.J., Evans,J.F., Gilliard,J.W. and Miller,D.K. (1990) Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature, 343, 282-284.
8. Mancini,J.A., Abramovitz,M., Cox,M.E., Wong,E., Charleson,S., Perrier,H., Wang,Z., Prasit,P and Vickers,P.J. (1993) 5-Lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett., 318, 277-281.
9. Samuelsonn,B., Dahlen,S.E., Lindgren,J.A., Rouzer,C.A. and Serhan,C.N. (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science, 237, 1171-1176.
10. Avis,I.M., Jett,M., Boyle,T., Vos,M.D., Moody,T., Treston,A.M., Martinez,A. and Mulshine,J.L. (1996) Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J. Clin. Invest., 97, 806-813.
11. 2. J. Biol. Chem., 263, 7567-7573.
12. Glasgow,W.C. and Eling,T.E. (1990) Epidermal growth factor stimulates linoleic acid metabolism in Balb/c 3T3 fibroblasts. Mol. Pharmacol., 38, 503-510.
13. 3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. Cancer Res., 48, 3106-3111.
14. Rao,C.V., Rivenson,A., Simi,B., Zang,E., Kelloff,G., Steele,V. and Reddy,B.S. (1995) Chemoprevention of colon Carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472.
15. Hussey,H.J. and Tisdale,M.J. (1996) Inhibition of growth by lipoxygenase inhibitors. Br. J. Cancer, 74, 683-687.
16. Bell,R.L., Bouska,J.B., Malo,P.E., Lanni,C., Harris,R.H., Otis,E.R., Stewart,A.O., Brooks,D.W. and Carter,G.W. (1995) Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors. J. Pharmacol. Exp. Ther., 272, 724-731.
17. Rouzer,C.A., Ford-Hutchinson,A.W., Morton,H.E. and Gilliard,J.W. (1990) MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem., 265, 1436-1442.
18. Hecht,S.S. and Hoffmann,D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875-884.
19. Wynder,E.L. and Hoffmann,D. (1994) Smoking and lung cancer: scientific challenges and opportunities. Cancer Res., 54, 5284-5295.
20. Hecht,S.S. (1994) Metabolic activation and detoxification of tobacco-specific nitrosamines - a model for cancer prevention strategies. Drug. Metab. Rev., 26, 373-390.
21. Weitberg,A.B. and Corverse,D. (1993) Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin. Genet., 43, 88-91.
22. Smith,T.J., Stoner,G.D. and Yang,C.S. (1995) Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res., 55, 5566-5573.
23. Hecht,S.S., Young,R. and Chen,C.B. (1980) Metabolism in the F344 rat of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. Cancer Res., 40, 4144-4150.
24. Depree,M., Friedman,B., Tanaka,W., VanHecken,A., Buntix,A. and De Shepper,P.J. (1993) Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesis inhibitor, in humans. Clin. Pharmacol. Ther., 53, 602-607.
25. Powell,W.S. (1982) Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol., 86, 467-477.
26. Pradelles,P., Grassi,J. and Maclouf,J. (1990) Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol., 187, 24-34.
27. 4 using acetylcholinesterase. Methods Enzymol., 187, 82-89.
28. Jorquera,R., Castonguay,A. and Schuller,H.M. (1992) Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes. Drug Metab. Dispos., 20, 510-517.
29. Lowry,O.H., Rosenbrough,N.J., Farr,L. and Randall,R.J. (1951) Protein measurements with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
30. Smith,T.J., Guo,Z., Thomas,P.E., Chung,F.-L., Morse,M.A., Elkind,K. and Yang,C.S. (1990) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res., 50, 6817-6822.
31. Castonguay,A., Lin,D., Stoner,G.D., Radok,P., Furaya,S.S., Hecht,S.S., Schut,A.G. and Klauning,J.E. (1983) Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues. Cancer Res., 43, 1223-1229.
32. Pan,Y.H.L., Nuzum,E., Hanson,L.A. and Beer,D.G. (1990) Ki-ras activation and expression in transformed mouse lung cell lines. Mol. Carcinogen., 3, 279-286.
33. Hansen,M.B., Nielson,S.E. and Berg,K. (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/ cell kill. J. Immnnol. Methods, 119, 203-210.
34. Holt,P.G. (1987) Immune and inflammatory function in cigarette smokers. Thorax, 42, 241-249.
35. Rioux,N. and Castonguay,A. (1997) Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone-induced immunosuppression in A/J mice by treatment with non steroidal antiinflammatory drugs. J. Natl Cancer Inst., 89, 874-880.
36. Castonguay,A. and Rioux,N. (1997) Inhibition of lung tumourigenesis by sulindac: comparaison of two experimental protocols. Carcinogenensis, 18, 491-496.
37. Gilliard,J. et al. (1989) L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. J. Can. Phys. Pharm., 5, 456-464.
38. Liu,M.C., Dube,L.M. and Lancaster,J. (1996) Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. J. Allergy Clin. Immunol., 98, 859-871.
39. Huovinen,E., Kaprio,J., Vesterinen,E. and Koskenvuo,M. (1997) Mortality of adults with asthma: a prospective cohort study. Thorax, 52, 49-54.
40. Wu,A.H., Fontham,E.T., Reynolds,P., Greenberg,R.S., Buffler,P., Liff,J., Boyd,P., Henderson,B.E. and Correa,P. (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am. J. Epidemiol., 141, 1023-1032.
41. Vesterinen,E., Pukkala,E., Timonen,T. and Aromaa,A. (1993) Cancer incidence among 78,000 asthmatic patients. Int. J. Epidemiol., 22, 976-982.
42. Jiang,H., Yamamoto,S. and Kato,R. (1994) Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor. Carcinogenesis, 15, 807-812.
43. Gabriel,S.E., Jaakkimainon,L. and Bombardier,C. (1991) Risk for serious gastrointestinal complication related to use of nonsteroidal anti-inflammatory drugs. Annls Intern. Med., 115, 787-796.
44. Clive,D.M. and Stoff,J.S. (1984) Renal syndromes associated with non-steroidal anti-inflammatory drugs. New Engl. J. Med., 310, 563-572.
45. Fries,J.F. (1991) NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J. Rheumatol., 28 (suppl.), 6-10.
46. Rose,D.P. and Connolly,J.M. (1990) Effects of fatty acids inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res., 50, 7139-7144.
47. Rouzer,C.A. and Samuelsson,B. (1985) On the nature of the 5-lipoxygenase reaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors. Proc. Natl Acad. Sci. USA, 82, 6040-6044.
48. Mansuy,D., Cucurou,C., Biatry,B. and Battioni,J.P. (1988) Soybean lipoxygenase-catalysed oxidations by linoleic acid hydroperoxide: different reducing substrates and dehydrogenation of phenidone and BW 755C. Biochem. Biophys. Res. Commun., 151, 339-346.
49. Kulkarni,A.P. and Cook,D.C. (1988) Hydroperoxidase activity of lipoxygenase: a potential pathway for xenobiotic metabolism in the presence of linoleic acid. Res. Commun. Chem. Pathol., 61, 305-314.